Cathepsin K serum levels were determinated in patients with bone metastases from breast cancer or prostate cancer in therapy with zoledronic acid or in patients or in patients with located breast or prostate cancer end in patients with non malignant diseases and in healthy blood. donors (control group). Cathepsin K serum levels were significantly more eleved in healthy subjects or in patients with peimary osteoporosis. Furthermore, the administration of Zoledronic acid to patients with metastatic bome disease from breast or prostate cancer, induced a marked increase of Cathepsin K serum levels.
TUMMINELLO FM, BADALAMENTI G, INCORVAIA L, FULFARO F, CRESCIMANNO M, FLANDINA C, et al. (2007). Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.. In In: SIF Abstracts Book, 33° Congresso Nazionale della Società Italiana di Farmacologia. (pp.Abs N.487-Abs N.487).
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.
TUMMINELLO, Francesca Maria;BADALAMENTI, Giuseppe;INCORVAIA, Lorena;CRESCIMANNO, Marilena;FLANDINA, Carla;GEBBIA, Nicolo';LETO, Gaetano
2007-01-01
Abstract
Cathepsin K serum levels were determinated in patients with bone metastases from breast cancer or prostate cancer in therapy with zoledronic acid or in patients or in patients with located breast or prostate cancer end in patients with non malignant diseases and in healthy blood. donors (control group). Cathepsin K serum levels were significantly more eleved in healthy subjects or in patients with peimary osteoporosis. Furthermore, the administration of Zoledronic acid to patients with metastatic bome disease from breast or prostate cancer, induced a marked increase of Cathepsin K serum levels.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
